We are live on ! Find out more
ICCC icon

ImmuCell
ICCC

21 hedge funds and large institutions have $6.32M invested in ImmuCell in 2016 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 6 increasing their positions, 5 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

20% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 5

1% more capital invested

Capital invested by funds: $6.29M → $6.32M (+$33K)

0% more funds holding

Funds holding: 21 → 21 (0)

Holders
21
Holders Change
–
Holders Change %
0%
% of All Funds
0.56%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
6
Reduced
5
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$50.6K
2
HA
Heartland Advisors
Wisconsin
+$12.6K
3
Wells Fargo
Wells Fargo
California
+$6.75K
4
Deutsche Bank
Deutsche Bank
Germany
+$4.73K
5
Vanguard Group
Vanguard Group
Pennsylvania
+$3.38K

Top Sellers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
-$70.9K
2
NC
Northpointe Capital
Michigan
-$12.2K
3
Walleye Trading
Walleye Trading
New York
-$5.73K
4
TRCT
Tower Research Capital (TRC)
New York
-$2.5K
5
UBS Group
UBS Group
Switzerland
-$2.14K
Name Holding Trade Value Shares
Change 		Change in
Stake
NC
1
Northpointe Capital
Michigan
$1.75M -$12.2K -1,807 -0.7%
HA
2
Heartland Advisors
Wisconsin
$1.41M +$12.6K +1,872 +0.9%
HP
3
HealthInvest Partners
Sweden
$1.16M – – –
PCM
4
Perritt Capital Management
Illinois
$570K – – –
Renaissance Technologies
5
Renaissance Technologies
New York
$443K +$50.6K +7,493 +13%
SRC
6
Shufro Rose & Co
New York
$291K – – –
Morgan Stanley
7
Morgan Stanley
New York
$173K -$70.9K -10,506 -30%
EFS
8
Essex Financial Services
Connecticut
$164K – – –
Vanguard Group
9
Vanguard Group
Pennsylvania
$158K +$3.38K +500 +2%
MA
10
Minerva Advisors
Pennsylvania
$101K – – –
UBS Group
11
UBS Group
Switzerland
$31K -$2.14K -317 -7%
Bank of America
12
Bank of America
North Carolina
$14K – – –
Acadian Asset Management
13
Acadian Asset Management
Massachusetts
$13K – – –
Deutsche Bank
14
Deutsche Bank
Germany
$12K +$4.73K +700 +65%
Royal Bank of Canada
15
Royal Bank of Canada
Ontario, Canada
$7K – – –
Wells Fargo
16
Wells Fargo
California
$7K +$6.75K +1,000 +100,000%
BFA
17
BlackRock Fund Advisors
California
$5K +$432 +64 +10%
UMA
18
USA Mutuals Advisors
Texas
$3K – – –
TRCT
19
Tower Research Capital (TRC)
New York
$2K -$2.5K -370 -53%
Creative Planning
20
Creative Planning
Kansas
$2K – – –
Walleye Trading
21
Walleye Trading
New York
– -$5.73K -849 -98%

ICCC Hedge Fund Activity: Q2 2016 in Review

21 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in ImmuCell (ICCC) for Q2 2016, worth a combined $6.32M — up 0.52% from $6.29M a quarter earlier.

Fund positioning in ICCC was balanced in Q2 2016: 0 funds opened new positions, 0 closed out, 6 added to existing stakes and 5 trimmed.

The largest buyer was Renaissance Technologies, adding an estimated $50.6K. The largest seller was Morgan Stanley, cutting an estimated $70.9K.

  • 21 institutional investors held ImmuCell (ICCC) as of Q2 2016, unchanged from Q1 2016.
  • Funds reported $6.32M of ImmuCell stock for Q2 2016, up 0.52% quarter-over-quarter.
  • 0 funds opened new ImmuCell positions in Q2 2016 and 0 closed out.
  • The largest ImmuCell buyer in Q2 2016 was Renaissance Technologies, an estimated $50.6K added.
  • The largest ImmuCell seller in Q2 2016 was Morgan Stanley, an estimated $70.9K sold.

Based on aggregated 13F filings for Q2 2016.